hydroxyproline has been researched along with ceruletide in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adler, G; Bachem, M; Lerch, MM; Turi, S; Weidenbach, H | 1 |
| Malagelada, JR; Molero, X; Salas, A; Tian, X; Vaquero, E | 1 |
| Asaumi, H; Nagashio, Y; Nomiyama, Y; Otsuki, M; Sugaya, T; Taguchi, M; Tashiro, M; Watanabe, S | 1 |
| Gao, J; Han, W; Qian, L; Shen, J; Wang, X; Wu, M; Xiang, D; Yang, L; Yu, Y; Zhang, J; Zhu, S | 1 |
4 other study(ies) available for hydroxyproline and ceruletide
| Article | Year |
|---|---|
Failure of a prolyl 4-hydroxylase inhibitor to alter extracellular matrix deposition during experimental pancreatitis.
Topics: Acute Disease; Animals; Ceruletide; DNA; Dose-Response Relationship, Drug; Enzyme Inhibitors; Extracellular Matrix; Extracellular Matrix Proteins; Gastrointestinal Agents; Hydroxyproline; Immunohistochemistry; Male; Microscopy, Electron; Pancreatitis; Procollagen-Proline Dioxygenase; Pyridines; Rats; Rats, Wistar; Spectrophotometry | 1997 |
Myofibroblast proliferation, fibrosis, and defective pancreatic repair induced by cyclosporin in rats.
Topics: Actins; Acute Disease; Animals; Cell Division; Ceruletide; Collagenases; Cyclosporine; Fibrosis; Gastrointestinal Agents; Hydroxyproline; Immunosuppressive Agents; Male; Pancreas; Pancreatitis; Rats; Rats, Wistar; Regeneration; Transforming Growth Factor beta | 1999 |
Angiotensin II type 1 receptor interaction is an important regulator for the development of pancreatic fibrosis in mice.
Topics: Animals; Ceruletide; Fibrosis; Hydroxyproline; Mice; Mice, Inbred C57BL; Mice, Knockout; Pancreas; Pancreatic Diseases; Protein Isoforms; Receptor, Angiotensin, Type 1; Recurrence; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |
Recombinant human interleukin-1 receptor antagonist (rhIL-1Ra) attenuates caerulein-induced chronic pancreatitis in mice.
Topics: Amylases; Animals; Ceruletide; Collagen; Disease Models, Animal; Fibrosis; Humans; Hydroxyproline; Injections, Intraperitoneal; Interleukin 1 Receptor Antagonist Protein; Interleukin-1beta; Lipase; Male; Mice; Mice, Inbred C57BL; Pancreatitis, Chronic | 2012 |